Related Experiment Video

Updated: Jul 6, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Vascular endothelial growth factor targeted RNA interference as a modulator of angiogenesis

Peter Celec1, Yoshikazu Yonemitsu

  • 1Institute of Pathophysiology, Faculty of Medicine, Comenius University, Bratislava, Slovak Republic. petercelec@gmail.com

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|April 15, 2008
PubMed

Insights

RNA interference is a promising tool to control blood vessel growth. This method targets vascular endothelial growth factor, offering potential for treating angiogenesis-related diseases like cancer and heart conditions.

Area of Science:

  • Biomedical science
  • Molecular biology
  • Genetics

Background:

  • Angiogenesis, or new blood vessel formation, plays a critical role in diseases such as cancer and ischemic heart disease.
  • Dysregulated angiogenesis contributes to the pathogenesis of various severe medical conditions.

Purpose of the Study:

  • To summarize the fundamental principles of using RNA interference to regulate angiogenesis.
  • To highlight the potential of vascular endothelial growth factor (VEGF) targeted RNA interference as a therapeutic strategy.

Main Methods:

  • Review of experimental approaches utilizing RNA interference (RNAi).
  • Focus on RNAi strategies targeting vascular endothelial growth factor (VEGF).

Main Results:

  • RNA interference demonstrates significant promise as a tool for modulating blood vessel growth.
  • VEGF-targeted RNAi is emerging as a key experimental approach.

Conclusions:

  • RNA interference offers a viable method for controlling angiogenesis.
  • Targeting VEGF with RNAi presents a promising avenue for therapeutic development in angiogenesis-related disorders.

More Related Videos

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles09:01

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles

Published on: September 27, 2013

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies09:03

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies

Published on: June 30, 2023

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...